AJP - Endo AJP: Endocrinology and Metabolism
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 260: E67-E74, 1991;
0193-1849/91 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mitrakou, A.
Right arrow Articles by Gerich, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mitrakou, A.
Right arrow Articles by Gerich, J.

AJP - Endocrinology and Metabolism, Vol 260, Issue 1 E67-E74, Copyright © 1991 by American Physiological Society


ARTICLES

Hierarchy of glycemic thresholds for counterregulatory hormone secretion, symptoms, and cerebral dysfunction

A. Mitrakou, C. Ryan, T. Veneman, M. Mokan, T. Jenssen, I. Kiss, J. Durrant, P. Cryer and J. Gerich
Department of Medicine, University of Pittsburgh, School of Medicine, PA 15261.

To define glycemic thresholds for activation of counterregulatory hormone secretion, initiation of symptoms (autonomic and neuroglycopenic), and onset of deterioration of cognitive function, we measured indexes of these responses during glycemic plateaus of 90, 78, 66, 54, and 42 mg/dl in 10 normal volunteers, with the use of the hyperinsulinemic glucose clamp technique. Activation of glucagon, epinephrine, norepinephrine, and growth hormone secretion began at arterialized venous plasma glucose concentrations of 68 +/- 1, 68 +/- 1, 65 +/- 1, and 67 +/- 2 (SE) mg/dl, respectively. Autonomic symptoms (anxiety, palpitations, sweating, irritability, and tremor) began at 58 +/- 2 mg/dl, which was significantly (P = 0.0001) lower. Neuroglycopenic symptoms (hunger, dizziness, tingling, blurred vision, difficulty thinking, and faintness) and deterioration in cognitive function tests began at 51 +/- 3 and 49 +/- 2 mg/dl, respectively, values that were both significantly (P = 0.018 and 0.004, respectively) lower than that for initiation of autonomic symptoms. We therefore conclude that there is a distinct hierarchy of responses to decrements in plasma glucose, such that the threshold for activation of counterregulatory hormone secretion occurs at higher plasma glucose levels than that for initiation of autonomic warning symptoms, which in turn occurs at higher plasma glucose levels than that for onset of neuroglycopenic symptoms and deterioration in cerebral function. Such a hierarchy would maximize the opportunity to avoid incapacitating hypoglycemia.


This article has been cited by other articles:


Home page
PhysiologyHome page
N. Marty, M. Dallaporta, and B. Thorens
Brain Glucose Sensing, Counterregulation, and Energy Homeostasis
Physiology, August 1, 2007; 22(4): 241 - 251.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
D. S. Ward, W. A. Voter, and S. Karan
The effects of hypo- and hyperglycaemia on the hypoxic ventilatory response in humans
J. Physiol., July 15, 2007; 582(2): 859 - 869.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
B. Raju and P. E. Cryer
Maintenance of the postabsorptive plasma glucose concentration: insulin or insulin plus glucagon?
Am J Physiol Endocrinol Metab, August 1, 2005; 289(2): E181 - E186.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
American Diabetes Association Workgroup on Hypogly
Defining and Reporting Hypoglycemia in Diabetes: A report from the American Diabetes Association Workgroup on Hypoglycemia
Diabetes Care, May 1, 2005; 28(5): 1245 - 1249.
[Full Text] [PDF]


Home page
Diabetes CareHome page
A. J. Sommerfield, I. J. Deary, V. McAulay, and B. M. Frier
Short-Term, Delayed, and Working Memory Are Impaired During Hypoglycemia in Individuals With Type 1 Diabetes
Diabetes Care, February 1, 2003; 26(2): 390 - 396.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
K. Igawa, M. Mugavero, M. Shiota, D. W. Neal, and A. D. Cherrington
Insulin Sensitively Controls the Glucagon Response to Mild Hypoglycemia in the Dog
Diabetes, October 1, 2002; 51(10): 3033 - 3042.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
H. Huopio, I. Vauhkonen, J. Komulainen, L. Niskanen, T. Otonkoski, and M. Laakso
Carriers of an Inactivating {beta}-Cell ATP-Sensitive K+ Channel Mutation Have Normal Glucose Tolerance and Insulin Sensitivity and Appropriate Insulin Secretion
Diabetes Care, January 1, 2002; 25(1): 101 - 106.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
E. W.M.T. ter Braak, A. M.M.F. Appelman, I. van der Tweel, D. W. Erkelens, and T. W. van Haeften
The Sulfonylurea Glyburide Induces Impairment of Glucagon and Growth Hormone Responses During Mild Insulin-Induced Hypoglycemia
Diabetes Care, January 1, 2002; 25(1): 107 - 112.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
P. E. Cryer
Hypoglycemia-associated autonomic failure in diabetes
Am J Physiol Endocrinol Metab, December 1, 2001; 281(6): E1115 - E1121.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
V. McAulay, I. J. Deary, S. C. Ferguson, and B. M. Frier
Acute Hypoglycemia in Humans Causes Attentional Dysfunction While Nonverbal Intelligence Is Preserved
Diabetes Care, October 1, 2001; 24(10): 1745 - 1750.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
S. A. Segel, C. G. Fanelli, C. S. Dence, J. Markham, T. O. Videen, D. S. Paramore, W. J. Powers, and P. E. Cryer
Blood-to-Brain Glucose Transport, Cerebral Glucose Metabolism, and Cerebral Blood Flow Are Not Increased After Hypoglycemia
Diabetes, August 1, 2001; 50(8): 1911 - 1917.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
J. M. Rosenthal, S. A. Amiel, L. Yaguez, E. Bullmore, D. Hopkins, M. Evans, A. Pernet, H. Reid, V. Giampietro, C. M. Andrew, et al.
The Effect of Acute Hypoglycemia on Brain Function and Activation: A Functional Magnetic Resonance Imaging Study
Diabetes, July 1, 2001; 50(7): 1618 - 1626.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
N. Flattem, K. Igawa, M. Shiota, M. G. Emshwiller, D. W. Neal, and A. D. Cherrington
{alpha}- and {beta}-Cell Responses to Small Changes in Plasma Glucose in the Conscious Dog
Diabetes, February 1, 2001; 50(2): 367 - 375.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
S. N. Davis, C. Shavers, and F. Costa
Differential gender responses to hypoglycemia are due to alterations in CNS drive and not glycemic thresholds
Am J Physiol Endocrinol Metab, November 1, 2000; 279(5): E1054 - E1063.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
J. S. Jacobs, R. Vallejo, G. J. DeSouza, and M. F. TerRiet
Severe Hypoglycemia After Labor Epidural Analgesia
Anesth. Analg., April 1, 2000; 90(4): 892 - 893.
[Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. Mevorach, J. Kaplan, C. J. Chang, L. Rossetti, and H. Shamoon
Hormone-independent activation of EGP during hypoglycemia is absent in type 1 diabetes mellitus
Am J Physiol Endocrinol Metab, March 1, 2000; 278(3): E421 - E429.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
P. Genter, N. Berman, M. Jacob, and E. Ipp
Counterregulatory hormones oscillate during steady-state hypoglycemia
Am J Physiol Endocrinol Metab, November 1, 1998; 275(5): E821 - E829.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
K. Pacak, M. Palkovits, G. Yadid, R. Kvetnansky, I. J. Kopin, and D. S. Goldstein
Heterogeneous neurochemical responses to different stressors: a test of Selye's doctrine of nonspecificity
Am J Physiol Regulatory Integrative Comp Physiol, October 1, 1998; 275(4): R1247 - R1255.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
F.J. Service
Hypoglycemic Disorders
N. Engl. J. Med., April 27, 1995; 332(17): 1144 - 1152.
[Full Text] [PDF]


Home page
NEJMHome page
A. Mitrakou, C. Fanelli, T. Veneman, G. Perriello, S. Calderone, D. Platanisiotis, A. Rambotti, S. Raptis, P. Brunetti, P. Cryer, et al.
Reversibility of Unawareness of Hypoglycemia in Patients with Insulinomas
N. Engl. J. Med., September 16, 1993; 329(12): 834 - 839.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online